Back to CELG-RI
Axiom Investment Management LLC → CELG-RI
Axiom Investment Management LLC CELG-RI Position History
Bristol-Myers Squibb Company Ce • Healthcare
Quarters held
20
Latest value
$32.9M
Q3 2026
Peak value
$625.2M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $3M |
| Q1 2026 | $6.4M |
| Q1 2026 | $32M |
| Q1 2026 | $42.8M |
| Q2 2026 | $807K |
| Q2 2026 | $1M |
| Q2 2026 | $2.9M |
| Q2 2026 | $3.4M |
| Q2 2026 | $4.9M |
| Q2 2026 | $6M |
| Q2 2026 | $7.5M |
| Q2 2026 | $11.9M |
| Q2 2026 | $22.8M |
| Q2 2026 | $30.4M |
| Q2 2026 | $625.2M |
| Q2 2026 | $625.2M |
| Q3 2026 | $3.1M |
| Q3 2026 | $6.6M |
| Q3 2026 | $6.9M |
| Q3 2026 | $32.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $32.9M | 527 | — | — |
| Q3 2026 | $6.9M | 110 | — | — |
| Q3 2026 | $6.6M | 105 | — | — |
| Q3 2026 | $3.1M | 50 | — | — |
| Q2 2026 | $625.2M | 10.8K | — | — |
| Q2 2026 | $625.2M | 10.8K | — | — |
| Q2 2026 | $30.4M | 527 | — | — |
| Q2 2026 | $22.8M | 396 | — | — |
| Q2 2026 | $11.9M | 207 | — | — |
| Q2 2026 | $7.5M | 131 | — | — |
| Q2 2026 | $6M | 105 | — | — |
| Q2 2026 | $4.9M | 85 | — | — |
| Q2 2026 | $3.4M | 59 | — | — |
| Q2 2026 | $2.9M | 50 | — | — |
| Q2 2026 | $1M | 18 | — | — |
| Q2 2026 | $807K | 14 | — | — |
| Q1 2026 | $42.8M | 705 | — | — |
| Q1 2026 | $32M | 527 | — | — |
| Q1 2026 | $6.4M | 105 | — | — |
| Q1 2026 | $3M | 50 | — | — |
Other funds holding CELG-RI
$11.1B
$9.6B
$8.5B
$7.9B
$5.9B
$5.9B
$5.8B